In-hospital complications and long-term outcomes of the paclitaxel drug-eluting stent in acute ST-elevation myocardial infarction: a real-world experience from a high-volume medical center

Cardiovascular Revascularization Medicine

Volumn 10, Issue 3, 2009, Pages 151-155

  Shammas, Nicolas W ^a   Shammas, Gail A ^a   Hahn, Alex ^a   Jerin, Michael ^a   Dippel, Eric J ^a   Winter, Matthew ^a  

^a MIDWEST CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

Author keywords

Acute ST elevation myocardial infarction; Paclitaxel eluting stent; Stent thrombosis; Target lesion revascularization

Indexed keywords

'TAXUS'; ABCIXIMAB; CLOPIDOGREL; ENOXAPARIN; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; PACLITAXEL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR RISK; CAUSE OF DEATH; DIABETES MELLITUS; DISEASE REGISTRY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HOSPITAL DISCHARGE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IN-STENT RESTENOSIS; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PATIENT COMPLIANCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVASCULARIZATION; SMOKING; ST SEGMENT ELEVATION; STENT THROMBOSIS; STROKE; TREATMENT OUTCOME; VASCULAR DISEASE;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; DRUG-ELUTING STENTS; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PACLITAXEL; PROSTHESIS DESIGN; RECURRENCE; REGISTRIES; RETROSPECTIVE STUDIES; SHOCK, CARDIOGENIC; STROKE; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 67649836054     PISSN: 15538389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carrev.2009.01.007     Document Type: Article

References (23)

1. Kastrati A., Dibra A., Spaulding C., Laarman G.J., Menichelli M., Valgimigli M., Di Lorenzo E., Kaiser C., Tierala I., Mehilli J., Seyfarth M., Varenne O., Dirksen M.T., Percoco G., Varricchio A., Pittl U., Syvänne M., Suttorp M.J., Violini R., and Schömig A. Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. Eur Heart J 28 (2007) 2706-2713
2. Brodie B.R., Stuckey T., Downey W., Humphrey A., Nussbaum M., Laurent S., Bradshaw B., Metzger C., Hermiller J., Krainin F., Juk S., Cheek B., Duffy P., Simonton C.A., and for the Strategic Transcatheter Evaluation of New Therapies (STENT) Group. Outcomes with drug-eluting stents versus bare metal stents in acute ST-elevation myocardial infarction: results from the Strategic Transcatheter Evaluation of New Therapies (STENT) Group. Catheter Cardiovasc Interv 72 (2008) 893-900
3. Romano M., Buffoli F., Tomasi L., Corrado L., Ferrari M.R., and Zanini R. Safety and effectiveness of drug eluting stent in patients with ST elevation myocardial infarction undergoing primary angioplasty. Catheter Cardiovasc Interv 71 (2008) 759-763
4. Kornowski R., Vaknin-Assa H., Lev E., Ben-Dor I., Teplitsky I., Rechavia E., Brosh D., Fuchs S., and Assali A. Clinical results of drug eluting stents compared to bare metal stents for patients with ST elevation acute myocardial infarction. Acute Card Care 10 (2008) 167-172
5. Percoco G., Manari A., Guastaroba P., Campo G., Guiducci V., Aurier E., Sangiorgio P., Passerini F., Geraci G., Piovaccari G., Naldi M., Saia F., Marzocchi A., and Real Investigators. Safety and long-term efficacy of sirolimus eluting stent in ST-elevation acute myocardial infarction: the REAL (Registro REgionale AngiopLastiche Emilia-Romagna) registry. Cardiovasc Drugs Ther 20 (2006) 63-68
6. van der Hoeven B.L., Liem S.S., Jukema J.W., Suraphakdee N., Putter H., Dijkstra J., Atsma D.E., Bootsma M., Zeppenfeld K., Oemrawsingh P.V., van der Wall E.E., and Schalij M.J. Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention Study. J Am Coll Cardiol 51 (2008) 618-626
7. Kelbaek H., Thuesen L., Helqvist S., Clemmensen P., Kløvgaard L., Kaltoft A., Andersen B., Thuesen H., Engstrøm T., Bøtker H.E., Saunamäki K., Krusell L.R., Jørgensen E., Hansen H.H., Christiansen E.H., Ravkilde J., Køber L., Kofoed K.F., Terkelsen C.J., Lassen J.F., and DEDICATION Investigators. Drug-eluting versus bare metal stents in patients with ST-segment-elevation myocardial infarction: eight-month follow-up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) trial. Circulation 118 (2008) 1155-1162 [Electronic publication]
8. De Luca G., Stone G.W., Suryapranata H., Laarman G.J., Menichelli M., Kaiser C., Valgimigli M., Di Lorenzo E., Dirksen M.T., Spaulding C., Pittl U., Violini R., Percoco G., and Marino P. Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. Int J Cardiol (2008) [Electronic publication ahead of print]
9. Menichelli M., Parma A., Pucci E., Fiorilli R., De Felice F., Nazzaro M., Giulivi A., Alborino D., Azzellino A., and Violini R. Randomized trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI). J Am Coll Cardiol 49 (2007) 1924-1930
10. Applegate R.J., Sacrinty M.T., Kutcher M.A., Baki T.T., Gandhi S.K., Santos R.M., and Little W.C. Comparison of drug-eluting versus bare metal stents on later frequency of acute myocardial infarction and death. Am J Cardiol 99 (2007) 333-338
11. Spaulding C., Henry P., Teiger E., Beatt K., Bramucci E., Carrié D., Slama M.S., Merkely B., Erglis A., Margheri M., Varenne O., Cebrian A., Stoll H.P., Snead D.B., Bode C., and TYPHOON Investigators. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 355 (2006) 1093-1104
12. Stone G, et al. The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: drug-eluting stent safe and effective in the setting of STEMI. Presented at TCT 2008, Washington DC.
13. Chechi T., Vittori G., Biondi Zoccai G.G., Vecchio S., Falchetti E., Spaziani G., Baldereschi G., Giglioli C., Valente S., and Margheri M. Single-center randomized evaluation of paclitaxel-eluting versus conventional stent in acute myocardial infarction (SELECTION). J Interv Cardiol 20 (2007) 282-291
14. Laarman G.J., Suttorp M.J., Dirksen M.T., van Heerebeek L., Kiemeneij F., Slagboom T., van der Wieken L.R., Tijssen J.G., Rensing B.J., and Patterson M. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med 355 (2006) 1105-1113
15. Daemen J., Tanimoto S., García-García H.M., Kukreja N., van de Sande M., Sianos G., de Jaegere P.P., van Domburg R.T., and Serruys P.W. Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries). Am J Cardiol 99 (2007) 1027-1032
16. Slottow T.L., Steinberg D.H., Roy P., Javaid A., Buch A.N., Okabe T., Xue Z., Smith K., Torguson R., Pichard A.D., Satler L.F., Suddath W.O., Kent K.M., and Waksman R. Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction. Cardiovasc Revasc Med 9 1 (2008) 24-28
17. Keeley E.C., Boura J.A., and Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361 (2003) 13-20
18. Lee J.H., Kim H.S., Lee S.W., Park J.H., Choi S.W., Jeong J.O., Cho Y., Lee N., Rhee K.S., Ko J.K., and Seong I.W. Prospective randomized comparison of sirolimus- versus paclitaxel-eluting stents for the treatment of acute ST-elevation myocardial infarction: pROSIT trial. Catheter Cardiovasc Interv 51 12 (2008) 1181-1187
19. Park K.W., Cho Y.S., Chung J.W., Yeon T.J., Chae I.H., Choi D.J., Oh B.H., Park Y.B., and Chung W.Y. One year clinical and six month angiographic results of drug eluting stents for ST elevation acute myocardial infarction: 'real world' comparison between sirolimus- and paclitaxel-eluting stents. Int J Cardiol 23 3 (2008) 353-354
20. Waksman R., Buch A.N., Torguson R., Xue Z., Smith K., Javaid A., Chu W.W., Satler L.F., Kent K.M., Pichard A.D., and REWARDS registry. Long-term clinical outcomes and thrombosis rates of sirolimus-eluting versus paclitaxel-eluting stents in an unselected population with coronary artery disease (REWARDS registry). Am J Cardiol 100 1 (2007) 45-51
21. Zhang Q., Shen J., Zhang R.Y., Qiu J.P., Lu J.D., Zhang Y., Chen Y.H., Zhang J.F., Zhang J.S., Hu J., Yang Z.K., Zheng A.F., Zhang X., and Shen W.F. Outcomes after primary coronary intervention with drug-eluting stent implantation in diabetic patients with acute ST elevation myocardial infarction. Chin Med J (Engl) 120 (2007) 1862-1867
22. Bose R., Gupta G., Grayburn P.A., Laible E.A., Kang M.J., and Choi J.W. Safety of drug-eluting stents in the coronary artery in ST-elevation myocardial infarction at a single high-volume medical center. Am J Cardiol 100 6 (2007) 949-952
23. Nakazawa G., Finn A.V., Joner M., Ladich E., Kutys R., Mont E.K., Gold H.K., Burke A.P., Kolodgie F.D., and Virmani R. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation 118 (2008) 1138-1145